Treatment of refractory secondary hyperparathyroidism with ethanol injection: The importance of glandular volume

Kidney International, Supplement

Volumn 63, Issue 85, 2003, Pages

  Douthat, Walter G ^a   Orozco, Santiago E ^b   De Arteaga, Javier ^b   Massari, Pablo U ^b  

^a Naciones Unidas 346   (Argentina)

^b NONE

Author keywords

Chronic renal failure; Hemodialysis; PEIT; Renal osteodystrophy

Indexed keywords

ALCOHOL; CALCIUM; CALCIUM PHOSPHATE; PARATHYROID HORMONE; PHOSPHATE;

CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CORRELATION ANALYSIS; DRUG ADMINISTRATION ROUTE; DYSPHAGIA; DYSPHONIA; ECHOGRAPHY; HUMAN; HYPOCALCEMIA; INJECTION; LOCAL ANESTHESIA; NECK; NECK DISCOMFORT; ORGAN SIZE; PARATHYROID HORMONE BLOOD LEVEL; PERCUTANEOUS DRUG ADMINISTRATION; PERCUTANEOUS ETHANOL INJECTION TREATMENT; PHOSPHATE BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SIDE EFFECT;

EID: 0038187786     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s85.24.x     Document Type: Conference Paper

References (27)

1. CANNATA J, DOUTHAT W: Avances en la etiopatogenia, el diagnóstico y el tratamiento de la osteodistrofia renal, En: Temas Actuales en Urología y Nefrología, editado por Pedro Barceló Reverte, Barcelona, Editorial Fundación Promoción Médica, 1994, pp 141-166
2. DOUTHAT W, ACUÑA G, MENÉNDEZ RODRIGUEZ P, CANNATA J: Hechos y controversias en el diagnóstico de certeza de la osteodistrofia renal. Papel de la biopsia ósea. Rev Port Nefrol Hipert 7:9-19, 1993
3. CANNATA J, DOUTHAT W, ACUÑA G, FERNÁNDEZ MARTÍN JL: Aluminium toxicity: The role of prevention. Life Chem Rep 11:207-213, 1994
4. MASSARI P: Disorders of bone and mineral metabolism after renal transplantation. Kidney Int 52:1412-1421, 1997
5. GROSSO S, DOUTHAT W, GARAY G, et al: Time course and functional correlates of post-transplant aluminum elimination. Nephrol Dial Transplant 13(Suppl 3:S98-S102, 1998
6. SOLBIATI L, GIANGRANDE A, DE PARA L, et al: Percutaneous ethanol injection of parathyroid tumors under US guidance: Treatment for secondary hyperparathyroidism. Radiology 155:607-610, 1985
7. GIANGRANDE A, CASTIGLIONI A, SOLBIATI L, ALLARIA P: Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 7:412-421, 1992
8. GIANGRANDE A, CASTIGLIONI A, SOLBIATI L, et al: Chemical parathyroidectomy for recurrence of secondary hyperparathyroidism. Am J Kidney Dis 24:421-426, 1994
9. FUKAGAWA M, KITAOKA M, TOMINAGA Y, et al: Selective percutaneous ethanol injection therapy (PEIT) of the parathyroid in chronic renal dialysis patients - The Japanese strategy. Nephrol Dial Transplant 14:2574-2577, 1999
10. KAKUTA T, FUKAGAWA M, FUJISAKI T, et al: Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color doppler flow mapping in chronic renal failure. Am J Kidney Dis 33:1091-1099, 1999
11. KITAOKA M, FUKAGAWA M, OGATA E, KUROKAWA K: Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. Kidney Int 46:1110-1117, 1994
12. CINTIN C, KARSTRUP S, LADEFOGED S, JOFFE P: Tertiary hyperparathyroidism treated by ultrasonically guided percutaneous fine-needle ethanol injection. Nephron 68:217-220, 1994
13. FLETCHER S, KANAGASUNDARAM N, RAYNER H. et al: Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol Dial Transplant 13:3111-3117, 1998
14. DOUTHAT W, GIRAUDO L, AGUIRRE E, et al: Eficacia y tolerancia del acetato vs carbonato de calcio como quelantes del fosforo en pacientes en dialisis. Nefrologia Latinoam 4:275-280, 1997
15. LOPEZ-HILKER A, DUSSO A, RAPP N, et al: Phosphorous restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 259:432-437, 1990
16. SLATOPOLSKY E, BURKE S, DILLON M: Group T: RenaGel®, a nonabsorbed calcium- and aluminum free phosphate binder, lowers serum phosphorus and parathyroid hormone. Kidney Int 55:299-307, 1999
17. ANTONSEN J, SHERRARD D, ANDRESS D: A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication. Kidney Int 53:223-227, 1998
18. BROWN AJ: Vitamin D analogues. Am J Kidney Dis 32(Suppl 2): S-25-S-39, 1998.
19. BLOCK G, PORT F: Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis 35:1226-1237, 2000
20. BLOCK G, HULBERT-SHEARON T, LEVIN N, PORT F: Association of serum phosphorous and calcium x phosphorous product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31:607-617, 1998
21. MALBERTI F, MARCELLI D, CONTE F, et al: Parathyroidectomy in patients on renal replacement therapy: An epidemiologic study. J Am Soc Nephrol 12:1242-1248, 2001
22. YUDD M, LLACH F: Parathyroidectomy in dialysis patients: Indications and postoperative management. In, Renal Osteodystrophy, edited by Bushinsky DA, Philadelphia, Lippincott-Raven Publishers, 1998, pp 403-20
23. JOHNSON W, MCCARTHY J, VAN HEERDEN J, et al: Results of subtotal parathyroidectomy in hemodialysis patients. Am J Med 84:23-32, 1988
24. TOMINAGA Y, NUMANO M, TANAKA Y, et al: Surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13:87-96, 1997
25. FUKAGAWA M, KITAOKA M, KUROKAWA K: Ultrasonographic intervention of parathyroid hyperplasia in chronic renal dialysis patients: A theoretical approach. Nephrol Dial Transplant 11(Suppl 3):S125-S129, 1996
26. FUKAGAWA M, KITAOKA M, YI H, et al: Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 68:221-228, 1994
27. LEFAUD G, BRENSILVER J, PIERCE J, et al: Persistent hypophosphatemia following parathyroidectomy in end stage renal disease. Clin Nephrol 13:40-43, 1980